Joint (NASDAQ:JYNT - Get Free Report) had its target price dropped by equities research analysts at Roth Mkm from $16.00 to $15.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Roth Mkm's target price would indicate a potential upside of 29.20% from the stock's current price.
Separately, StockNews.com lowered shares of Joint from a "buy" rating to a "hold" rating in a report on Thursday.
Check Out Our Latest Research Report on Joint
Joint Stock Down 2.3 %
Shares of NASDAQ JYNT traded down $0.27 during trading on Friday, reaching $11.61. The company had a trading volume of 85,338 shares, compared to its average volume of 68,190. Joint has a 12-month low of $7.31 and a 12-month high of $17.82. The business's 50-day moving average is $11.26 and its 200 day moving average is $12.96. The stock has a market cap of $174.15 million, a PE ratio of -11.85 and a beta of 1.57.
Joint (NASDAQ:JYNT - Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.05). The firm had revenue of $30.26 million for the quarter, compared to analysts' expectations of $29.65 million. Joint had a negative net margin of 12.00% and a positive return on equity of 2.17%. On average, analysts anticipate that Joint will post 0.13 earnings per share for the current year.
Institutional Trading of Joint
Large investors have recently made changes to their positions in the stock. Squarepoint Ops LLC bought a new position in Joint during the second quarter valued at approximately $144,000. Sargent Investment Group LLC purchased a new position in shares of Joint in the 2nd quarter worth $150,000. XTX Topco Ltd purchased a new position in shares of Joint in the 2nd quarter worth $174,000. Price T Rowe Associates Inc. MD grew its holdings in shares of Joint by 5.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company's stock worth $229,000 after acquiring an additional 837 shares during the period. Finally, Avondale Wealth Management increased its position in Joint by 15.8% during the second quarter. Avondale Wealth Management now owns 22,000 shares of the company's stock valued at $309,000 after acquiring an additional 3,000 shares during the last quarter. 76.88% of the stock is currently owned by institutional investors.
About Joint
(
Get Free Report)
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Featured Stories
Before you consider Joint, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.
While Joint currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
